Anti-inflammatory effects of GLP-1 medicines independent of weight loss Several GLP-1 medicines, including semaglutide, liraglutide, and exenatide, reduce plasma levels of C-reactive protein (CRP), a surrogate of systemic inflammation, in people with obesity or T2D
What are the common side effects of Saxenda, Ozempic, and Wegovy
Semaglutide, manufactured by Novo Nordisk, known by its brand name Wegovy, for weight loss and Ozempic, for diabetes management, harnesses the power of GLP-1 receptor agonists, to modulate blood sugar and facilitate weight management
From your first consultation, youll experience the difference of working with medical professionals who take the time to understand your health goals
In a retrospective study, researchers found that patients with opioid use disorder who had a GLP-1 prescription had a 40% lower rate of opioid overdoses compared with those without a prescription